PER, CTX-M, TEM and SHV Beta-lactamases in Clinical Isolates of Klebsiella pneumoniae Isolated from Tehran, Iran

Publish Year: 1389
نوع سند: مقاله ژورنالی
زبان: English
View: 170

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-13-3_007

تاریخ نمایه سازی: 3 آبان 1400

Abstract:

Objective(s) Different types of extended spectrum beta-lactamases (ESBLs) are encountered in the clinical settings worldwide. There are a few studies regarding the prevalence of ESBL genes among Klebsiella pneumoniae isolates at Tehran especially those of blaPER and blaCTX. The aim of this study was to determine the prevalence of blaSHV, blaTEM ,blaPER and blaCTX genes among clinical K. pneumoniae of different hospitals in Tehran. Materials and Methods Two hundred isolates of K. pneumoniae were received from different clinical specimens. The susceptibility of the isolates to ۱۰ different antibiotics was examined by disk diffusion test. The MICs for ceftazidime were also determined using micro-broth dilution assay. Isolates showing MIC> ۴ gg/ml for ceftazidime were screened for ESBL production by phenotypic confirmatory test (PCT) and subjected to PCR for studied genes. Variation among four amplified genes was evaluated using PCR-RFLP. Results By disk diffusion test, resistance to ceftazidime and cefotaxime were ۳۴.۷% and ۳۳.۵% respectively. However, all strains were susceptible to imipenem. Eighty isolates showed MICs> ۴ gg/ml for ceftazidime of which ۷۷ (۹۶%) were positive for ESBL in PCT. The prevalence of blaSHV, blaCTX_M, blaTEM and blaPER among these isolates were ۲۶%, ۲۴.۵%, '۸% and ۷.۵%, respectively. No variation was detected in the genes by PCR-RFLP. Conclusion As far as we know this is the first report of the blaPER-I in K. pneumoniae in Iran. The blaCTX_M was the second most common gene detected among the ESBL positive isolates of K. pneumoniae. For rapid identification of ESBL producing isolates it was recommended that clinical laboratories adopt simple test based on CLSI recommendation for confirming ESBL production in enterobacterial species.

Authors

Leila Nasehi

Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran

Fereshteh Shahcheraghi

Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran

Vajihe Sadat Nikbin

Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran

Shoeib Nematzadeh

Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • ۱.Monnet DL, Archibald LK, Phillips L, Tenover FC, McGowan JE ...
  • ۲.Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, ...
  • ۳.Iroha IR, Egwu OA, Ngozi AT, Chidiebube NA, Chika EP.Extended ...
  • ۴.Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas ...
  • ۵.Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection ...
  • ۶.Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases.: a clinical update. Clin ...
  • ۷.Shahcheraghi F, Moezi H, Feizabadi MM. Distribution of TEM and ...
  • ۸.Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, ...
  • ۹.Aminzadeh Z,Sadat Kashi M, Sha'bani M. Bacteriuria by extended-spectrum Beta-lactamase ...
  • ۱۰.Ramazanzadeh R, Chitsaz M, Bahmani N. Prevalence and antimicrobial susceptibility ...
  • ۱۱.Bazzaz BS, Naderinasab M, Mohamadpoor AH, Farshadzadeh Z, Ahmadi S, ...
  • ۱۲.Feizabadi MM, Delfani S, Raji N, Majnooni A, Aligholi M, ...
  • ۱۳.Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens:epidemiology, taxonomy, ...
  • ۱۴.National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial ...
  • ۱۵.National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution ...
  • ۱۶.National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial ...
  • ۱۷.Johnson A, Woodford N. Plasmid analysis. In: Johnson A, Woodford ...
  • ۱۸.Branger C, Lesimple AL, Bruneau B, Berry P, Lambert-Zechovsky N. ...
  • ۱۹.Mendes C, Kiffer C, Segura A, Ribeiro J, Turner P. ...
  • ۲۰.Putman M, VanVeen HW, Konings WN.Molecular properties of bacterial multidrug ...
  • ۲۱.Silva۱ N, Oliveira M, Bandeira۱ AC, Brites C. Risk factors ...
  • ۲۲.Jeong SH, Bae IK, Lee JH, Sohn SG ,Kang GH, ...
  • ۲۳.Lal P, Kapil A, Das BK, Sood S. Occurrence of ...
  • ۲۵.Pages JM, Lavigne JP, Leflon-Guibout V, Marcon E, Bert F, ...
  • ۲۶.Ananthan S, Subha A. Cefoxitin resistance mediated by loss of ...
  • ۲۷.Nathisuwan S,Burgess DS.Extended-spectrum beta-lactamases: epidemiology,detection, and treatment. Pharmacotherapy ۲۰۰۱; ۲۱:۹۲۰-۹۲۸ ...
  • ۲۸.Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, ...
  • ۲۹.Olson AB, Silverman M, Boyd DA, McGeer A, Willey BM, ...
  • ۳۰.Bernard H, Tancrede C, Livrelli V, Morand A, Barthelemy M, ...
  • ۳۱.Paterson DL, Ko WC Von Gottberg A, Mohapatra S, Casellas ...
  • ۳۲.Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, ...
  • ۳۳.Livermore DM, Hawkey PM, CTX-M: Changing the face of ESBLs ...
  • ۳۴.Luzzaro F, Mezzatesta M, Mugnaioli C, Perilli M, Stefani S, ...
  • ۳۵.Ahmed AM, Nakano H, Shimamoto T. The first characterization of ...
  • ۳۶.Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum ...
  • نمایش کامل مراجع